VAERS Explorer
Back to explore

Report #2825827

Received Feb 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
66 yrs
State
NM
Recovered
Unknown
Vaccinated
Feb 5, 2025
Onset
Feb 6, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK—IM

Symptoms (3)

MyalgiaPyrexiaRash

Symptom narrative

sore muscles; fever; rash; This non-serious case was reported by a consumer via call center representative and described the occurrence of muscle soreness in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 05-FEB-2025, the patient received Shingrix (intramuscular). On 06-FEB-2025, 1 days after receiving Shingrix, the patient experienced muscle soreness (Verbatim: sore muscles), fever (Verbatim: fever) and rash (Verbatim: rash). The outcome of the muscle soreness, fever and rash were unknown. It was unknown if the reporter considered the muscle soreness, fever and rash to be related to Shingrix. It was unknown if the company considered the muscle soreness, fever and rash to be related to Shingrix. Additional Information: GSK Receipt Date: 06-FEB-2025 The reporter reported that a patient received his Shingrix vaccination and reporting day morning he awoke with fever, muscle aches and rash on his stomach and arms.